Clinical data | |
---|---|
Other names | EM-652; SCH-57068 |
Drug class | Selective estrogen receptor modulator |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C29H31NO4 |
Molar mass | 457.570 g·mol−1 |
3D model (JSmol) | |
| |
|
Acolbifene (INN ) (developmental code names EM-652, SCH-57068) is a nonsteroidal selective estrogen receptor modulator (SERM) which, as of 2015, is in phase III clinical trials for the treatment of breast cancer.[1][2]